Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 1/20 | 0.70 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.70 |
| ▸ | ACHE | P22303 | 5/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.32 |
| ▸ | ALPL | P05186 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALPG | P10696 | 1/20 | 0.32 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5164341 | 0.97 | APOBEC3A (0.67) | APOBEC3AAPOBEC3GACHETP53KDM4E | |
| SCHEMBL2385111 | 0.86 | APOBEC3A (0.82) | APOBEC3AAPOBEC3GACHETP53KDM4E | |
| SCHEMBL12020269 | 0.86 | APOBEC3A (0.93) | APOBEC3AAPOBEC3GACHETP53KDM4E | |
| SCHEMBL147815 | 0.86 | APOBEC3A (0.93) | APOBEC3AAPOBEC3GACHETP53KDM4E | |
| Alcohol SCHEMBL27837339 | 0.84 | APOBEC3A (0.70) | APOBEC3AAPOBEC3GACHETP53KDM4E | |
| Bromide SCHEMBL10995909 | 0.83 | APOBEC3A (0.88) | APOBEC3AAPOBEC3GACHETP53KDM4E | |
| Water SCHEMBL35582 | 0.83 | APOBEC3A (0.88) | APOBEC3AAPOBEC3GACHETP53KDM4E | |
| Bromide SCHEMBL80469 | 0.83 | APOBEC3A (0.88) | APOBEC3AAPOBEC3GACHETP53KDM4E | |
| SCHEMBL7546894 | 0.83 | APOBEC3A (0.88) | APOBEC3AAPOBEC3GACHETP53KDM4E | |
| Bromide SCHEMBL238552 | 0.83 | APOBEC3A (0.88) | APOBEC3AAPOBEC3GACHETP53KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3330311-B1 | STORAGE STABLE 1K-POLYURETHANE-PREPREGS AND MOULDED ARTICLE MADE FROM SAME ON THE BASIS OF A POLYURETHANE COMPOSITION | EVONIK OPERATIONS GMBH (DE) | 2021-05-05 | — | — | EP | claimed |
| US-10633519-B2 | Storage-stable polyurethane prepregs and mouldings produced therefrom composed of a polyurethane composition with liquid resin components | EVONIK OPERATIONS GMBH (DE) | 2020-04-28 | — | — | US | claimed |
| US-10626236-B2 | Storage-stable one-component polyurethane prepregs and shaped bodies composed of polyurethane composition that have been produced therefrom | EVONIK OPERATIONS GMBH (DE) | 2020-04-21 | — | — | US | claimed |
| US-20180155515-A1 | STORAGE-STABLE ONE-COMPONENT POLYURETHANE PREPREGS AND SHAPED BODIES COMPOSED OF POLYURETHANE COMPOSITION THAT HAVE BEEN PRODUCED THEREFROM | EVONIK OPERATIONS GMBH (DE) | 2018-06-07 | — | — | US | claimed |
| EP-2411439-B1 | PREPEGS AND MOLDED BODIES PRODUCED THEREOF AT LOW TEMPERATURE | EVONIK DEGUSSA GMBH (DE) | 2016-11-16 | — | — | EP | claimed |
| EP-2188320-B1 | DUAL CURE FORMULATIONS WITH COMPONENTS COMPRISING URETDIONE GROUPS | EVONIK DEGUSSA GMBH (DE) | 2014-05-14 | — | — | EP | claimed |
| US-20140087613-A1 | STORAGE-STABLE POLYURETHANE PREPREGS AND MOULDINGS PRODUCED THEREFROM COMPOSED OF A POLYURETHANE COMPOSITION WITH LIQUID RESIN COMPONENTS | EVONIK DEGUSSA GMBH (DE) | 2014-03-27 | — | — | US | claimed |
| US-8455090-B2 | Prepegs and molded bodies produced thereof at low temperature | EVONIK DEGUSSA GMBH (DE) | 2013-06-04 | — | — | US | claimed |
| US-20120003890-A1 | PREPEGS AND MOLDED BODIES PRODUCED THEREOF AT LOW TEMPERATURE | EVONIK DEGUSSA GMBH (DE) | 2012-01-05 | — | — | US | claimed |
| US-20110224458-A1 | PREPARATION OF METHIONINE OR SELENOMETHIONINE FROM HOMOSERINE VIA A 4-SUBSTITUTED 2-AMINOBUTANOIC ACID INTERMEDIATE | NOVUS INTERNATIONAL INC. (US) | 2011-09-15 | — | — | US | claimed |
| US-20100227942-A1 | DUAL-CURE FORMULATIONS WITH COMPONENTS CONTAINING URETDIONE GROUPS | EVONIK DEGUSSA GMBH (DE) | 2010-09-09 | — | — | US | claimed |
| EP-1560833-B1 | PREPARATION OF CODEINE FROM MORPHINE | MALLINCKRODT INTERNAT CORP (US) | 2007-03-14 | — | — | EP | claimed |
| EP-1560833-A2 | PREPARATION OF CODEINE FROM MORPHINE | Mallinckrodt International Corporation (US) | 2005-08-10 | — | — | EP | claimed |
| WO-2004037826-A2 | PREPARATION OF CODEINE FROM MORPHINE | MALLINCKRODT INC. (US) | 2004-05-06 | — | — | WO | claimed |
| US-6579985-B1 | Preparation of codeine from morphine | MALLINCKRODT INC. | 2003-06-17 | — | — | US | claimed |
| US-10793664-B2 | Process for preparing trimers and/or oligomers of diisocyanates | EVONIK OPERATIONS GMBH (DE) | 2020-10-06 | — | — | US | disclosed |
| US-10633519-B2 | Storage-stable polyurethane prepregs and mouldings produced therefrom composed of a polyurethane composition with liquid resin components | EVONIK OPERATIONS GMBH (DE) | 2020-04-28 | — | — | US | disclosed |
| EP-0268710-B1 | IMPROVED PROCESS FOR THE PREPARATION OF CODEINE FROM MORPHINE | Council of Scientific and Industrial Research (IN) | 1991-05-15 | — | — | EP | disclosed |
| US-4764615-A | Process for the preparation of codeine from morphine | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1988-08-16 | — | — | US | disclosed |
| EP-0268710-A1 | Improved process for the preparation of codeine from morphine | Council of Scientific and Industrial Research (IN) | 1988-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224458-A1 | PREPARATION OF METHIONINE OR SELENOMETHIONINE FROM HOMOSERINE VIA A 4-SUBSTITUTED 2-AMINOBUTANOIC ACID INTERMEDIATE | MTR, CBS, ABAT | APOBEC3A 3356/4885APOBEC3G 3619/4885ACHE 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.